CXCL8 and fibromyalgia: Finally, one review found that the difference in levels of IL-6, IL-8, TNF-α, and brain-derived neurotrophic factor (BDNF) may have the potential to be used for stratification of patients with fibromyalgia into subgroups for future targeted therapies [21].